Systems-biology Approaches for Decoding Persistent Coxsackievirus B3 Infection
解码持续性柯萨奇病毒 B3 感染的系统生物学方法
基本信息
- 批准号:8511124
- 负责人:
- 金额:$ 23.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-03-01 至 2015-02-28
- 项目状态:已结题
- 来源:
- 关键词:ATF2 geneAcuteAddressAffectAgonistArchitectureBiochemicalBiological AssayBiological ModelsCREB1 geneCardiac MyocytesCardiotoxicityCaspaseCell DeathCellsChildChronicChronic PhaseCleaved cellCoxsackie VirusesCoxsackievirus InfectionsCytokine SignalingDataDiseaseEventFeedbackGene ExpressionGenesGenomeGoalsHalf-LifeHeartHeart TransplantationHeart failureIn VitroInfectionInfiltrationInflammationInflammatoryInterventionLeast-Squares AnalysisLinkLymphocyteLytic PhaseMAPK14 geneMAPK8 geneMeasurementMeasuresMediator of activation proteinMessenger RNAMethodsModelingMolecularMonitorMyocarditisMyocardiumPathogenesisPathway interactionsPatientsPhasePhosphoric Monoester HydrolasesPhosphotransferasesPlayPolyproteinsRNARNA StabilityRecombinantsRegulationRoleRouteSignal PathwaySignal TransductionStagingStimulusStructural ProteinSystemSystems BiologyTechnologyTestingTimeTissuesTranscriptTranslatingUntranslated RegionsUp-RegulationViralVirusVirus DiseasesWorkbasecombinatorialcomputerized data processingcytokinedesignfascinateinsightmRNA Decaymathematical modelmethod developmentnew therapeutic targetnoveloutcome forecastpathogenpublic health relevancereconstitutionresponsetranscription factorviral RNAyoung adult
项目摘要
DESCRIPTION (provided by applicant): Coxsackievirus B3 (CVB3) is a leading cause of chronic heart inflammation and heart failure in children and young adults. Persistent CVB3 infection is not associated with the mature virus but instead with latent expression of its RNA genome in cardiomyocytes. Our preliminary observations suggest that the presence of CVB3 RNA disrupts how cardiomyocytes normally respond to inflammatory stimuli, which may be important for establishing a chronically inflamed state. The objective of this proposal is to defin the molecular "rewiring" that takes place in cardiomyocytes upon chronic infection with CVB3. Our hypothesis is that persistent expression of CVB3 RNA disrupts the posttranscriptional signaling response of cardiomyocytes to proinflammatory stimuli. During the R21 phase, we will develop high-throughput biochemical methods to measure signaling and transcript stability at the systems level. In the R33 phase, these assays will be combined to examine posttranscriptional signal processing in cultured cardiomyocytes expressing CVB3 RNA and stimulated with proinflammatory cytokines. The data will ultimately serve as the basis for a computational-systems model that connects signaling events to gene expression and transcript stability. Aim #1 of the R21 phase is to develop quantitative, systems-level bioassays to measure kinase-phosphatase activation in cardiomyocytes chronically infected with CVB3. Aim #2 of the R21 phase is to develop a real-time, multiplex RNA stability assay for profiling half-lif regulation of NF-?B transcripts in cardiomyocytes. Aim #3 of the R33 phase is to interrogate intracellular dynamics triggered by proinflammatory cytokines and build a predictive, data-driven systems model that captures CVB3-induced cardiomyocyte rewiring. The long-term goal is to use the model to propose novel interventions that can correct posttranscriptional signal processing in patients with persistent CVB3 infection.
描述(由申请人提供):柯萨奇病毒 B3 (CVB3) 是儿童和年轻人慢性心脏炎症和心力衰竭的主要原因。持续的 CVB3 感染与成熟病毒无关,而是与其 RNA 基因组在心肌细胞中的潜在表达有关。我们的初步观察表明,CVB3 RNA 的存在扰乱了心肌细胞对炎症刺激的正常反应,这对于建立慢性炎症状态可能很重要。该提案的目的是定义慢性感染 CVB3 后心肌细胞中发生的分子“重新布线”。我们的假设是,CVB3 RNA 的持续表达会破坏心肌细胞对促炎刺激的转录后信号反应。在R21阶段,我们将开发高通量生化方法来测量系统水平的信号传导和转录稳定性。在 R33 阶段,这些测定将结合起来检查表达 CVB3 RNA 并用促炎细胞因子刺激的培养心肌细胞的转录后信号处理。这些数据最终将作为计算系统模型的基础,将信号事件与基因表达和转录稳定性联系起来。 R21 阶段的目标#1 是开发定量的系统级生物测定法,以测量慢性感染 CVB3 的心肌细胞中的激酶磷酸酶激活情况。 R21 阶段的目标#2 是开发一种实时、多重 RNA 稳定性测定,用于分析心肌细胞中 NF-κB 转录本的半衰期调节。 R33 阶段的目标#3 是探究促炎细胞因子触发的细胞内动力学,并建立一个预测性、数据驱动的系统模型来捕获 CVB3 诱导的心肌细胞重新布线。长期目标是利用该模型提出新的干预措施,以纠正持续 CVB3 感染患者的转录后信号处理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin A Janes其他文献
Kevin A Janes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin A Janes', 18)}}的其他基金
Interdisciplinary Training in Systems & Biomolecular Data Science
系统跨学科培训
- 批准号:
10631096 - 财政年份:2022
- 资助金额:
$ 23.39万 - 项目类别:
Open phase-separation models for cancer systems biology
癌症系统生物学的开放相分离模型
- 批准号:
10829012 - 财政年份:2022
- 资助金额:
$ 23.39万 - 项目类别:
Systems Analysis of Stress-adapted Cancer Organelles (SASCO) Center
应激适应癌症细胞器系统分析 (SASCO) 中心
- 批准号:
10703471 - 财政年份:2022
- 资助金额:
$ 23.39万 - 项目类别:
A premalignant chronology of cell-state variability in basal-like breast cancer
基底样乳腺癌细胞状态变异的癌前年表
- 批准号:
10737809 - 财政年份:2022
- 资助金额:
$ 23.39万 - 项目类别:
A premalignant chronology of cell-state variability in basal-like breast cancer
基底样乳腺癌细胞状态变异的癌前年表
- 批准号:
10366411 - 财政年份:2022
- 资助金额:
$ 23.39万 - 项目类别:
A synthetic systems biology approach to predict context-specific mechanisms for SHP2 functional activity and resistance to SHP2 inhibition
一种合成系统生物学方法,用于预测 SHP2 功能活性和 SHP2 抑制抗性的特定机制
- 批准号:
10831287 - 财政年份:2022
- 资助金额:
$ 23.39万 - 项目类别:
A premalignant chronology of cell-state variability in basal-like breast cancer
基底样乳腺癌细胞状态变异的癌前年表
- 批准号:
10540784 - 财政年份:2022
- 资助金额:
$ 23.39万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Pathogen-induced immune and stress responses mediated by bZIP transcription factors
bZIP 转录因子介导的病原体诱导的免疫和应激反应
- 批准号:
10676256 - 财政年份:2021
- 资助金额:
$ 23.39万 - 项目类别:
Pathogen-induced immune and stress responses mediated by bZIP transcription factors
bZIP 转录因子介导的病原体诱导的免疫和应激反应
- 批准号:
10493353 - 财政年份:2021
- 资助金额:
$ 23.39万 - 项目类别:
Pathogen-induced immune and stress responses mediated by bZIP transcription factors
bZIP 转录因子介导的病原体诱导的免疫和应激反应
- 批准号:
10366502 - 财政年份:2021
- 资助金额:
$ 23.39万 - 项目类别:
CD73 is a multi-functional protein that regulates liver injury
CD73是一种调节肝损伤的多功能蛋白
- 批准号:
9882993 - 财政年份:2017
- 资助金额:
$ 23.39万 - 项目类别:
Non-platelet P2Y Receptor in Vascular Inflammation and Thrombogenesis
非血小板 P2Y 受体在血管炎症和血栓形成中的作用
- 批准号:
9237082 - 财政年份:2017
- 资助金额:
$ 23.39万 - 项目类别: